The interaction between liver cirrhosis, infection by Streptococcus bovis, and colon cancer

Eur J Clin Microbiol Infect Dis. 2023 Jul;42(7):907-912. doi: 10.1007/s10096-023-04618-5. Epub 2023 May 5.

Abstract

Whether cirrhotic patients with Streptococcus bovis bacteremia have an increased risk of colorectal neoplasm is uncertain. A multicentric retrospective cohort study was conducted investigating associations between S. bovis biotype and species, cirrhosis, and colorectal neoplasm. Out of 779 patients with S. bovis bacteremia, 69 (8.7%) had cirrhosis. No differences were found in the prevalence of colorectal neoplasm between cirrhotic and non-cirrhotic patients undergoing colonoscopy. Among cirrhotic patients, prevalence of colorectal neoplasms was higher in S. bovis biotype I (S. gallolyticus) bacteremia (80%) than in S. bovis biotype II (33.3%; p < 0.007). In conclusion, risk of colorectal neoplasm is high among cirrhotic patients with S. gallolyticus bacteremia.

Keywords: Bacteriemia; Colonoscopy; Colorectal neoplasm; Liver cirrhosis; Streptococcus bovis.

MeSH terms

  • Bacteremia* / complications
  • Bacteremia* / epidemiology
  • Bacteremia* / microbiology
  • Colonic Neoplasms* / complications
  • Colonic Neoplasms* / epidemiology
  • Colorectal Neoplasms* / microbiology
  • Humans
  • Liver Cirrhosis / complications
  • Retrospective Studies
  • Streptococcal Infections* / complications
  • Streptococcal Infections* / epidemiology
  • Streptococcal Infections* / microbiology
  • Streptococcus bovis*